GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Total Stockholders Equity

Read-Gene (WAR:RDG) Total Stockholders Equity : zł1.23 Mil (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Read-Gene Total Stockholders Equity?

Read-Gene's Total Stockholders Equity for the quarter that ended in Sep. 2024 was zł1.23 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Read-Gene's Book Value per Share for the quarter that ended in Sep. 2024 was zł0.10. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Read-Gene's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.00.

Read-Gene Total Stockholders Equity Historical Data

The historical data trend for Read-Gene's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Read-Gene Total Stockholders Equity Chart

Read-Gene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.14 4.06 5.42 5.51 4.16

Read-Gene Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.53 4.16 3.53 1.50 1.23

Read-Gene  (WAR:RDG) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Read-Gene's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.23-0)/11.79
=0.10

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Read-Gene's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 1.23
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Read-Gene Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Read-Gene's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Read-Gene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Total Stockholders Equity
Comparable Companies
WAR:PUR WAR:GX1 WAR:NNG WAR:SCS WAR:PHR WAR:PFM WAR:URT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY
Traded in Other Exchanges
N/A
Address
Ulica Alabastrowa 8, Grzepnica, Dobra, POL, 72-003
Website
http://www.read-gene.com
Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.

Read-Gene Headlines

No Headlines